Researchers at the Fisher Center for Alzheimer’s Disease Research laboratory published “Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimer’s Disease” in Nature online. Drs. Gen He (lead author) and Paul Greengard…
Category: News
Nanobiotechnology To Fight Cancer And Other Illnesses
Two new groundbreaking scientific papers by researchers at UC Santa Barbara demonstrate the synthesis of nanosize biological particles with the potential to fight cancer and other illnesses. The studies introduce new approaches…
Risk Of Surgery Lower Than Reported In Recent Studies
A new multi-center study of 854 children with Crohn’s disease shows a 5-year cumulative risk of bowel surgery is significantly lower than reported in recent studies. The findings of the study, led…
Young Black Women At Increased Risk Of Self-Harm
Young, Black women are significantly more likely to self-harm than people from other ethnic groups, according to new research published in the September issue of the British Journal of Psychiatry. And people…
High levels of OPG hormone impacts adverse outcome after myocardial infarction
Patients suffering with heart failure are more likely to die if they have high levels of a bone hormone called osteoprotegerin (OPG). That is the finding of a research team from the…
Prometheus launches Crohn’s Prognostic test
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn’s Prognostic test. This novel and unique diagnostic represents a significant advance in the…
High vitamin D level improves survival rate in heart failure patients
Survival rates in heart failure patients with reduced levels of vitamin D are lower than in patients with normal levels. This is the finding of a major study carried out at University…
Discovery Of New Protein That Gets To The Roots Of Obesity And Osteoporosis
Here’s good news for anyone trying to lose weight or has osteoporosis: Scientists from Maine are on the trail of a weight loss drug that may revolutionize how we treat these two…
Swiss Breast Cancer Patient Becomes First In World To Receive Treatment Using Gated RapidArc From Varian Medical Systems
A 51-year-old breast cancer patient from Switzerland has become the first person in the world to be treated using Gated RapidArc®, which makes it possible to monitor patient breathing and compensate for…
Antibiotic helps fight common wound infection
CHICAGO – An antibiotic that gets its microbe-fighting power from insect proteins was effective at attacking a common infection that afflicts blast victims in war zones, U.S. researchers said Wednesday. The antimicrobial…
Finding Suggests New Aim for Alzheimer’s Drugs
In a year when news about Alzheimer’s disease seems to whipsaw between encouraging and disheartening, a new discovery by an 84-year-old scientist has illuminated a new direction. The scientist, Paul Greengard, who…
Too little sleep bad for teenagers’ diets
Teenagers who sleep less than eight hours a night on weeknights eat more fatty foods and snacks than those who get more than eight hours of sleep a night, U.S. researchers said…
Botox Maker Settles Case for $600 Million
The specialty pharmaceutical company Allergan has agreed to pay $600 million to settle civil and criminal accusations that it illegally marketed Botox, the drug used in antiwrinkle injections, for medical uses for…
Michael Douglas’ cancer therapy is grueling
Actor Michael Douglas says he is upbeat in spite of a diagnosis of advanced throat cancer, which he discussed Tuesday on The Late Show With David Letterman. Douglas, 65, told Letterman that…
Scotland Registration Statistics Don’t Tell Full Story, Says BDA
Figures for the number of individuals registered with an NHS dentist published by NHS Scotland today do not tell the full story, according to the British Dental Association (BDA). Commenting on the…